← Open Payments lookup

CHRISTOPHER COLOPINTO: Open Payments

NPI 1659341923 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,848 in 123 payments from 25 companies in 2025. Trend: 2023 $1,850 · 2024 $2,333 · 2025 $2,848

Food & beverage: $2,848
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$548
Novo Nordisk Inc11$323
Kowa Pharmaceuticals America, Inc.17$315
Otsuka America Pharmaceutical, Inc.8$241
Merck Sharp & Dohme LLC12$221
Amgen Inc.19$187
Bayer Healthcare Pharmaceuticals Inc.5$186
Takeda Pharmaceuticals U.S.A., Inc.11$146
Madrigal Pharmaceuticals1$141
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$82

Products named: ZORYVE, REXULTI, AIRSUPRA, Ozempic, BREZTRI, Kerendia, CAPVAXIVE, TRINTELLIX.

Industry payments across NJ — which companies pay providers there.